David Dickens
Impact in
- Biochemistry top 5%
- Amino Acid Enzymes and Metabolism
Papers in
- Oncology 9
- Drug Transport and Resistance Mechanisms 9
-
- Pharmacological Effects and Toxicity Studies 6
- Co-authors
- Munir Pirmohamed (12 shared papers)Andrew Owen (7 shared papers)S.S. Hasnain (2 shared papers)S.V. Antonyuk (2 shared papers)Athina Giannoudis (3 shared papers)Ana Alfirevic (6 shared papers)Steven D. Webb (1 shared paper)Ignacio A. Romero (2 shared papers)
- Journals
- Molecular Pharmaceutics (3 papers)Biochemical Pharmacology (3 papers)Pharmacogenomics (1 paper)Scientific Reports (1 paper)Frontiers in Pediatrics (1 paper)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
David Dickens
19 papers receiving 498 citations
David Dickens's Hit Papers
Peers
Comparison fields: 5 of 86
- Biochemistry 131
- Biological Psychiatry 24
- Oncology 192
- Neurology 45
- Pediatrics, Perinatology and Child Health 106
Countries citing papers authored by David Dickens
This map shows the geographic impact of David Dickens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Dickens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Dickens more than expected).
Fields of papers citing papers by David Dickens
This network shows the impact of papers produced by David Dickens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Dickens. The network helps show where David Dickens may publish in the future.
Co-authors
The 25 scholars most cited alongside David Dickens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 105 | |
| 2 | 2011 | 70 | |
| 3 | 2017 | 62 | |
| 4 | 2020 | 29 | |
| 5 | 2009 | 29 | |
| 6 | 2022 | 28 | |
| 7 | 2018 | 28 | |
| 8 | 2013 | 26 | |
| 9 | 2013 | 24 | |
| 10 | Crossing the blood–brain barrier: emerging therapeutic strategies for neurological disease Hit paper breakdown → | 2025 | 22 |
| 11 | 2011 | 19 | |
| 12 | 2021 | 18 | |
| 13 | 2015 | 13 | |
| 14 | 2020 | 13 | |
| 15 | 2022 | 7 | |
| 16 | 2014 | 5 | |
| 17 | 2024 | 5 | |
| 18 | 2021 | 2 | |
| 19 | 2017 | 2 |
About David Dickens
David Dickens is a scholar working on Oncology, Pediatrics, Perinatology and Child Health, Biochemistry, Molecular Biology and Cellular and Molecular Neuroscience, having authored 19 papers that have together received 507 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (9 papers), Pharmacological Effects and Toxicity Studies (6 papers), Amino Acid Enzymes and Metabolism (5 papers), Neuroscience and Neuropharmacology Research (4 papers), Hemoglobinopathies and Related Disorders (2 papers), Parkinson's Disease Mechanisms and Treatments (2 papers), Tryptophan and brain disorders (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Biochemistry (131 citations), Biological Psychiatry (24 citations), Oncology (192 citations), Neurology (45 citations) and Pediatrics, Perinatology and Child Health (106 citations). David Dickens has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Munir Pirmohamed, Andrew Owen, S.S. Hasnain, S.V. Antonyuk, Athina Giannoudis, Ana Alfirevic, Steven D. Webb, Ignacio A. Romero, Pierre‐Olivier Couraud and Babette B. Weksler. Their work appears in journals such as Molecular Pharmaceutics, Biochemical Pharmacology, Pharmacogenomics, Scientific Reports and Frontiers in Pediatrics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.